Brief: Ultimovacs Q4 Total Loss Was NOK 70.5 Mln
16/02/2023 07:16
Feb 16 (Reuters) - Ultimovacs ASA ULTI.OL :
* Q4 TOTAL LOSS WAS MNOK 70.5 FOR PERIOD AND MNOK 167.8 IN
FY
2022.
Source text for Eikon: ID:nGNE84K35Q
Further company coverage: ULTI.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant